Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DN.1.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.626ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.626ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.626ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.626NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.629ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.629ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.629ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.629NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GA.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GA.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.61 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.61 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.61 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.61 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.75.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.75.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GC.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GC.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GC.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.524ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.524ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.524ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.524NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.38NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.15.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.15.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.15.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.15.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.59 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.59 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.59 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.59 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBRORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used